188 related articles for article (PubMed ID: 32840426)
41. 2008 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 26th Annual Report.
Bronstein AC; Spyker DA; Cantilena LR; Green JL; Rumack BH; Giffin SL
Clin Toxicol (Phila); 2009 Dec; 47(10):911-1084. PubMed ID: 20028214
[TBL] [Abstract][Full Text] [Related]
42. Suspected suicides and nonfatal suicide attempts involving antidepressants reported to United States poison control centers, 2000-2020.
Francis M; Spiller HA; Badeti J; Funk AR; Casavant MJ; Michaels NL; Zhu M; Smith GA
Clin Toxicol (Phila); 2022 Jul; 60(7):818-826. PubMed ID: 35188444
[TBL] [Abstract][Full Text] [Related]
43. Cannabinoids: Medical implications.
Schrot RJ; Hubbard JR
Ann Med; 2016; 48(3):128-41. PubMed ID: 26912385
[TBL] [Abstract][Full Text] [Related]
44. Characterization of edible marijuana product exposures reported to United States poison centers.
Cao D; Srisuma S; Bronstein AC; Hoyte CO
Clin Toxicol (Phila); 2016 Nov; 54(9):840-846. PubMed ID: 27418198
[TBL] [Abstract][Full Text] [Related]
45. Adolescent exposures to traditional and novel psychoactive drugs, reported to National Poison Data System (NPDS), 2007-2017.
Ng PC; Banerji S; Graham J; Leonard J; Wang GS
Drug Alcohol Depend; 2019 Sep; 202():1-5. PubMed ID: 31279256
[TBL] [Abstract][Full Text] [Related]
46. Poisoning exposure cases involving e-cigarettes and e-liquid in the United States, 2010-2018.
Wang B; Liu S; Persoskie A
Clin Toxicol (Phila); 2020 Jun; 58(6):488-494. PubMed ID: 31496321
[No Abstract] [Full Text] [Related]
47. Synthetic cannabinoid use among college students.
Mathews EM; Jeffries E; Hsieh C; Jones G; Buckner JD
Addict Behav; 2019 Jun; 93():219-224. PubMed ID: 30772774
[TBL] [Abstract][Full Text] [Related]
48. Marijuana Exposure Among Children Younger Than Six Years in the United States.
Onders B; Casavant MJ; Spiller HA; Chounthirath T; Smith GA
Clin Pediatr (Phila); 2016 May; 55(5):428-36. PubMed ID: 26054783
[TBL] [Abstract][Full Text] [Related]
49. Synthetic cannabinoid use in a nationally representative sample of US high school seniors.
Palamar JJ; Acosta P
Drug Alcohol Depend; 2015 Apr; 149():194-202. PubMed ID: 25736618
[TBL] [Abstract][Full Text] [Related]
50. Marijuana and the Pediatric Population.
Dharmapuri S; Miller K; Klein JD
Pediatrics; 2020 Aug; 146(2):. PubMed ID: 32661188
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of quetiapine abuse and misuse reported to poison centers.
Klein-Schwartz W; Schwartz EK; Anderson BD
J Addict Med; 2014; 8(3):195-8. PubMed ID: 24662370
[TBL] [Abstract][Full Text] [Related]
52. Characterization of intentional-abuse venlafaxine exposures reported to poison control centers in the United States.
Leonard JB; Klein-Schwartz W
Am J Drug Alcohol Abuse; 2019; 45(4):421-426. PubMed ID: 30973750
[No Abstract] [Full Text] [Related]
53. The Future of Substance Abuse Now: Relationships among Adolescent Use of Vaping Devices, Marijuana, and Synthetic Cannabinoids.
Tai H; Swartz MD; Marsden D; Perry CL
Subst Use Misuse; 2021; 56(2):192-204. PubMed ID: 33412950
[No Abstract] [Full Text] [Related]
54. Exposure Calls to U. S. Poison Centers Involving Electronic Cigarettes and Conventional Cigarettes-September 2010-December 2014.
Chatham-Stephens K; Law R; Taylor E; Kieszak S; Melstrom P; Bunnell R; Wang B; Day H; Apelberg B; Cantrell L; Foster H; Schier JG
J Med Toxicol; 2016 Dec; 12(4):350-357. PubMed ID: 27352081
[TBL] [Abstract][Full Text] [Related]
55. Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….
Baron EP
Headache; 2015 Jun; 55(6):885-916. PubMed ID: 26015168
[TBL] [Abstract][Full Text] [Related]
56. Medical use of cannabis products: Lessons to be learned from Israel and Canada.
Ablin J; Ste-Marie PA; Schäfer M; Häuser W; Fitzcharles MA
Schmerz; 2016 Feb; 30(1):3-13. PubMed ID: 26767992
[TBL] [Abstract][Full Text] [Related]
57. Common marijuana-related cases encountered in the emergency department.
Heard K; Marlin MB; Nappe T; Hoyte CO
Am J Health Syst Pharm; 2017 Nov; 74(22):1904-1908. PubMed ID: 28947626
[No Abstract] [Full Text] [Related]
58. Trends and characteristics of ocular exposures related to e-cigarettes and e-liquids reported to Poison Control Centers in the United States, 2010-2019.
Wang B; Liu ST; Johnson MA; Trigger S
Clin Toxicol (Phila); 2022 Mar; 60(3):279-285. PubMed ID: 34328369
[TBL] [Abstract][Full Text] [Related]
59. Medical cannabis vs. synthetic cannabinoids: What does the future hold?
Bolognini D; Ross RA
Clin Pharmacol Ther; 2015 Jun; 97(6):568-70. PubMed ID: 25761845
[TBL] [Abstract][Full Text] [Related]
60. Causes of therapeutic errors in older adults: evaluation of National Poison Center data.
Hayes BD; Klein-Schwartz W; Gonzales LF
J Am Geriatr Soc; 2009 Apr; 57(4):653-8. PubMed ID: 19220563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
